je.st
news
Tag: authorization
Fonon Corporation (Formerly Mabwe Minerals Inc.) Receives Clearance from FINRA Including Authorization for 10:1 stock split and Issued New Ticker Symbol: FNON
2015-09-09 12:31:09| Industrial Newsroom - All News for Today
Mabwe Minerals is now Fonon Corporation, completes Phase I of company's 2015 Reorganization Plan with FINRA approval of name change, domicile change, stock split and new ticker symbol Lake Mary, Florida, - Fonon Corporation (formerly Mabwe Minerals) (OTC: FNON) is pleased to announce the company has successfully...
Tags: new
including
stock
corporation
Veteran Affairs Request and Authorization to Release HMIS Information
2015-09-04 22:08:59| PortlandOnline
ServicePoint Users only, Please transact ROI as trained and return completed form to PHB Questions? Contact Wendy Smith or Hunter Belgard PDF Document, 385kbCategory: Multnomah County Resources
Tags: information
request
release
affairs
Environmental Services Company Expands Capabilities with New Authorization to Transport Ebola Suspected or Confirmed Medical Waste
2015-08-07 12:31:18| Industrial Newsroom - All News for Today
SWS Environmental Services recently acquired a new operating permit from the United States Department of Transportation. Panama City Beach, FL SWS Environmental Services (SWSES) has been granted "Party Status" by the United States Department of Transportation (USDOT), Pipeline and Hazardous Materials Safety...
Tags: services
company
medical
transport
Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
2015-08-03 19:27:07| Biotech - Topix.net
OraSure Technologies, Inc. , a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administration Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test for use with fingerstick and venous whole blood. This test has not been cleared or approved by FDA.
Tags: test
technologies
rapid
emergency
Merck Announces European Medicines Agency Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection
2015-07-23 17:02:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1, 3, 4 or 6 infection.1 The EMA will initiate review of the MAA under accelerated assessment timelines. Language: English Contact: Merck & Co., Inc.Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
application
marketing
treatment
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »